Demand for Unapproved Weight-Loss Drug Surges on Social Media

(MedPage Today) — The FDA has warned six online companies against selling the compound retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers. Five American companies and one in Germany received similar comments…